Get full access to this article View all access and purchase options for this article. Data availability statement Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. References 1. Naci H, Fleurence R, Birt J, et al. Economic burden of multiple sclerosis. Pharmacoeconomics 2010; 28(5): 363–379. 2. Kobelt G, Thompson A, Berg J, et al. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler 2017; 23(8): 1123–1136. 3.